Pyrr and/or Flip,
In reviewing the SITC seminar schedule a series of "Hot Topics" breakout sessions on 11/19 look interesting to me for DCVax implications. Being a layperson on this science I wonder if you could enlighten with your expertise if this one has Roche looking in our direction:
"511 – Hot Topic Symposium I: Accelerating Tumor Immunity with Agonist Antibodies
Anti-CD40 Agonist Antibody - The Ideal Combination Partner for Cancer Immunotherapy
calendar11/9/2014clock11:20 AM - 11:45 AMclockRoom: Woodrow Wilson A
Hy Levitsky, MD
Global Head, Cancer Immunology Experimental Medicine, Roche Pharma Research and Early Development, Schlieren 8952, Switzerland"
Thanks in advance.